Concepedia

Publication | Open Access

Mutant FLT3: A Direct Target of Sorafenib in Acute Myelogenous Leukemia

DOIFull Paper Access

338

Citations

38

References

2008

Year

Weiguo Zhang, Marina Konopleva, Yue-Xi Shi, Teresa McQueen, David Harris, Xiaoyang Ling, Zeev Estrov, Alfonso Quintás‐Cardama, Donald Small, Jörge E. Cortes,
JNCI Journal of the National Cancer Institute

Abstract

Sorafenib may have therapeutic efficacy in AML patients whose cells harbor FLT3-ITD mutations.

References

YearCitations

Page 1